Trial Oversight and Funding
HEART
This study comports with the Transparency and Openness Promotion Guidelines for authors publishing in the American Heart Association Journal, and the data sets can be made available by reasonable request to the corresponding author.The study was a multicenter (conducted within 6 clinical sites), prospective, single-arm, nonsignificant risk, consecutively enrolled diagnostic yield device clinical trial. The trial was run between October 6, 2020 and October 21, 2021. Specific details about methodology, including prespecified outcomes, were published previously.